Gerd A Kullak-Ublick

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 10

Top Topics

Clinical Evaluation

Top Venues

JMIR formative research

Journal of medical Internet research

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas Trojan, Christian Kühne, Michael Kiessling, Johannes Schumacher, Stefan Dröse, Christian F Singer, Christian Jackisch, Christoph Thomssen, Gerd A Kullak-Ublick
Impact of Electronic Patient-Reported Outcomes on Unplanned Consultations and Hospitalizations in Patients With Cancer Undergoing Systemic Therapy: Results of a Patient-Reported Outcome Study Compared With Matched Retrospective Data. JMIR formative research 8 (2024)
Andreas Trojan, Sven Roth, Ziad Atassi, Michael Kiessling, Reinhard Zenhaeusern, Yannick Kadvany, Johannes Schumacher, Gerd A Kullak-Ublick, Matti Aapro, Alexandru E Eniu
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes. JMIR cancer 10 (2024)
Andreas Trojan, Sven Roth, Ziad Atassi, Michael Kiessling, Reinhard Zenhaeusern, Yannick Kadvany, Johannes Schumacher, Gerd A Kullak-Ublick, Matti Aapro, Alexandru E Eniu
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes. JMIR cancer 10 (2024)
Andreas Trojan, Christian Kühne, Michael Kiessling, Johannes Schumacher, Stefan Dröse, Christian F Singer, Christian Jackisch, Christoph Thomssen, Gerd A Kullak-Ublick
Impact of Electronic Patient-Reported Outcomes on Unplanned Consultations and Hospitalizations in Patients With Cancer Undergoing Systemic Therapy: Results of a Patient-Reported Outcome Study Compared With Matched Retrospective Data. JMIR formative research 8 (2024)
Andreas Trojan, Sven Roth, Ziad Atassi, Michael Kiessling, Reinhard Zenhaeusern, Yannick Kadvany, Johannes Schumacher, Gerd A Kullak-Ublick, Matti Aapro, Alexandru E Eniu
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes. JMIR cancer 10 (2024)
Andreas Trojan, Christian Kühne, Michael Kiessling, Johannes Schumacher, Stefan Dröse, Christian F Singer, Christian Jackisch, Christoph Thomssen, Gerd A Kullak-Ublick
Impact of Electronic Patient-Reported Outcomes on Unplanned Consultations and Hospitalizations in Patients With Cancer Undergoing Systemic Therapy: Results of a Patient-Reported Outcome Study Compared With Matched Retrospective Data. JMIR formative research 8 (2024)
Jane I Grove, Camilla Stephens, María Isabel Lucena, Raúl Jesús Andrade, Sabine Weber, Alexander L Gerbes, Einar Stefan Björnsson, Guido Stirnimann, Ann K Daly, Matthias Hackl, Kseniya Khamina-Kotisch, Jose J G Marin, Maria J Monte, Sara A Paciga, Melanie Lingaya, Shiva S Forootan, Christopher E P Goldring, Oliver Poetz, Rudolf Lombaard, Alexandra Stege, Helgi K Bjorrnsson, Mercedes Robles-Diaz, Dingzhou Li, Thi Dong Binh Tran, Shashi K Ramaiah, Sophia L Samodelov, Gerd A Kullak-Ublick, Guruprasad Padur Aithal, null null
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control study. Diagnostic and prognostic research 7 (1) (2023)
Edmond Atallah, Cristiana Freixo, Ismael Alvarez-Alvarez, Francisco Javier Cubero, Alexander L Gerbes, Gerd A Kullak-Ublick, Guruprasad Padur Aithal
Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review. Expert opinion on drug metabolism & toxicology 17 (11) (2021)
Zhibo Gai, Lei Chu, Zhenqiang Xu, Xiaoming Song, Dongfeng Sun, Gerd A Kullak-Ublick
Farnesoid X receptor activation protects the kidney from ischemia-reperfusion damage. Scientific reports 7 (1) (2017)
Marco Egbring, Elmira Far, Malgorzata Roos, Michael Dietrich, Mathis N Brauchbar, Gerd A Kullak-Ublick, Andreas Trojan
A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical Trial. Journal of medical Internet research 18 (9) (2016)